Hennings H, Lowry D T, Yuspa S H, Mock B, Potter M
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892, USA.
Mol Carcinog. 1997 Sep;20(1):143-50. doi: 10.1002/(sici)1098-2744(199709)20:1<143::aid-mc16>3.0.co;2-1.
To develop mouse strains useful for studies of susceptibility and resistance to the induction of skin tumors, three new inbred SENCAR strains were independently derived by random inbreeding of outbred SENCAR mice. Characterization of these mice for sensitivity to skin tumor development indicated that mice of all three strains displayed increased sensitivity to initiation by 7,12-dimethylbenz[a]anthracene (DMBA), urethane, or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA). Promotion by mezerein as well as carcinogenesis by repeated treatment with DMBA or MNNG produced papillomas with a high frequency of conversion to squamous cell carcinomas (SCCs). Compared with outbred SENCAR mice, development of both squamous papillomas and carcinomas was increased at least two-fold by all protocols tested. The F1 hybrid between SENCARA/Pt males and resistant BALB/cAnPt females was resistant to the induction of both papillomas and SCCs after initiation by 2 microg of DMBA and promotion by 20 weekly applications of 2 microg of TPA. Papillomas developed in all of the SENCARA/Pt mice, none of the BALB/cAnPt mice, and 12% of the F1 progeny. Thus, at these doses of initiator and promoter, resistance was incompletely dominant in the F1 hybrid. However, the responsiveness of the F1 mice could be increased substantially by increasing the dose of the promoter.
为培育出可用于皮肤肿瘤易感性和抗性研究的小鼠品系,通过对远交系SENCAR小鼠进行随机近亲繁殖,独立培育出了三个新的近交SENCAR品系。对这些小鼠皮肤肿瘤发生敏感性的特征分析表明,所有三个品系的小鼠对7,12-二甲基苯并[a]蒽(DMBA)、氨基甲酸乙酯或N-甲基-N'-硝基-N-亚硝基胍(MNNG)引发以及12-O-十四酰佛波醇-13-乙酸酯(TPA)促癌均表现出更高的敏感性。芫花酯素促癌以及DMBA或MNNG重复处理致癌均产生了高频率转化为鳞状细胞癌(SCC)的乳头状瘤。与远交SENCAR小鼠相比,所有测试方案均使鳞状乳头状瘤和癌的发生至少增加了两倍。SENCARA/Pt雄性小鼠与抗性BALB/cAnPt雌性小鼠的F1杂种在经2μg DMBA引发和每周20次涂抹2μg TPA促癌后,对乳头状瘤和SCC的诱导具有抗性。所有SENCARA/Pt小鼠均发生了乳头状瘤,所有BALB/cAnPt小鼠均未发生,而F1后代中有12%发生了乳头状瘤。因此,在这些引发剂和促癌剂剂量下,抗性在F1杂种中不完全显性。然而,通过增加促癌剂剂量可显著提高F1小鼠的反应性。